127
Views
32
CrossRef citations to date
0
Altmetric
Review Article

Special population considerations and regulatory affairs for clinical research

, , , , , & show all
Pages 45-54 | Received 20 Nov 2014, Accepted 19 Dec 2014, Published online: 16 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Cataldo Patruno, Luca Potestio, Massimiliano Scalvenzi, Teresa Battista, Flavia Raia, Vincenzo Picone, Gabriella Fabbrocini & Maddalena Napolitano. (2022) Dupilumab for the treatment of adult atopic dermatitis in special populations. Journal of Dermatological Treatment 33:7, pages 3028-3033.
Read now
Martyn Howard, Jill Barber, Naved Alizai & Amin Rostami-Hodjegan. (2018) Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 14:12, pages 1315-1330.
Read now
Luca Monaco, Mauro Melis, Chiara Biagi, Monia Donati, Ester Sapigni, Alberto Vaccheri & Domenico Motola. (2017) Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance. Expert Opinion on Drug Safety 16:3, pages 271-275.
Read now

Articles from other publishers (29)

Edilainy Rizzieri Caleffi‐Marchesini, Amanda Antunes Herling, Julia Macente, Rodolfo Hernandes Bonan, Priscila de Freitas Lima, Rafaela Moreno, Veriano Alexandre, Nitin Bharat Charbe, Fernanda Belincanta Borghi‐Pangoni, Rodrigo Cristofoletti & Andréa Diniz. (2023) Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process. CPT: Pharmacometrics & Systems Pharmacology.
Crossref
Radin Alikhani & Manjunath P. Pai. (2023) Reconsideration of the current models of estimated kidney function‐based drug dose adjustment in older adults: The role of biological age. Clinical and Translational Science 16:11, pages 2095-2105.
Crossref
Gautam Vijaywargi, Sivacharan Kollipara, Tausif Ahmed & Siddharth Chachad. (2022) Predicting transporter mediated drug–drug interactions via static and dynamic physiologically based pharmacokinetic modeling: A comprehensive insight on where we are now and the way forward. Biopharmaceutics & Drug Disposition 44:3, pages 195-220.
Crossref
Shekhar NeemaRohit KothariAradhana RoutSiddharth ManiSiddharth BhattSunmeet Sandhu. (2023) Systemic treatment of psoriasis in special population. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-8.
Crossref
Ricardo P. Garay. (2023) Recent clinical trials with stem cells to slow or reverse normal aging processes. Frontiers in Aging 4.
Crossref
Piera Polidori, Despina Makridaki & Stephanie Kohl. (2023) Clinical trials. European Journal of Hospital Pharmacy, pages ejhpharm-2022-003471.
Crossref
Jody D. Ciolino, Alexander M. Kaizer & Lauren Balmert Bonner. (2023) Guidance on interim analysis methods in clinical trials. Journal of Clinical and Translational Science 7:1.
Crossref
Kevin L. Zacharoff. 2023.
Stephen H. Curry & Robin Whelpton. 2022. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics 249 274 .
Jeffrey S. BarrettJeffrey S. Barrett. 2022. Fundamentals of Drug Development. Fundamentals of Drug Development 199 217 .
Jeffrey S. Barrett. (2022) Editorial: Insights in obstetric and pediatric pharmacology: 2021. Frontiers in Pharmacology 13.
Crossref
Nicolas Cottura, Hannah Kinvig, Sandra Grañana‐Castillo, Adam Wood & Marco Siccardi. (2022) Drug–Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives. The Journal of Clinical Pharmacology 62:7, pages 835-846.
Crossref
Maha Ali Alghamdi, Antonino N. Fallica, Nicola Virzì, Prashant Kesharwani, Valeria Pittalà & Khaled Greish. (2022) The Promise of Nanotechnology in Personalized Medicine. Journal of Personalized Medicine 12:5, pages 673.
Crossref
Yang Zhong, Xingyu Zhang, Lijun Zhou, Lei Li & Tao Zhang. (2021) Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019. BMC Pediatrics 21:1.
Crossref
Manjunath P. Pai & Ryan L. Crass. (2021) Translation of Pharmacodynamic Biomarkers of Antibiotic Efficacy in Specific Populations to Optimize Doses. Antibiotics 10:11, pages 1368.
Crossref
Maram Suresh Gupta, Tegginamath Pramod Kumar, Devegowda Vishkante Gowda & Jessica M. Rosenholm. (2021) Orodispersible films: Conception to quality by design. Advanced Drug Delivery Reviews 178, pages 113983.
Crossref
Thaciana dos Santos Alcântara, Fernando Castro de Araújo Neto, Helena Ferreira Lima, Dyego Carlos S. Anacleto de Araújo, Júlia Mirão Sanchez, Giulyane Targino Aires-Moreno, Carina de Carvalho Silvestre & Divaldo P. de Lyra Junior. (2020) Prevalence of medication discrepancies in pediatric patients transferred between hospital wards. International Journal of Clinical Pharmacy 43:4, pages 909-917.
Crossref
Devendra Choudhary, Hanmant Goykar, Dnyaneshwar Kalyane, Nimeet Desai & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations 29 82 .
Luis Armando Solano-Sandí, Mónica Cambronero-Valverde & Guadalupe Herrera-Watson. (2020) Identification and analysis of ongoing registered clinical intervention trials on COVID-19. Medwave 20:09, pages e8051-e8051.
Crossref
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein & Anette Müllertz. (2020) Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 147, pages 105280.
Crossref
Steve Sussman, Shanna K. Kattari, Lourdes Baezconde-Garbanati & Shane N. Glackin. (2019) Commentary: The Problems of Grouping All Adversity Into a Special Populations Label. Evaluation & the Health Professions 43:1, pages 66-70.
Crossref
Magdalena Kasendra, Raymond Luc, Jianyi Yin, Dimitris V Manatakis, Gauri Kulkarni, Carolina Lucchesi, Josiah Sliz, Athanasia Apostolou, Laxmi Sunuwar, Jenifer Obrigewitch, Kyung-Jin Jang, Geraldine A Hamilton, Mark Donowitz & Katia Karalis. (2020) Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model. eLife 9.
Crossref
Chi Chiu Wang, Lu Li, Yi Feng Shao, Xue Kui Liu, Wing Hung Tam & Rui Man Li. (2019) Chinese herbal medicines for treating gestational diabetes mellitus. Cochrane Database of Systematic Reviews.
Crossref
Giulia Lorenzoni, Rosanna Irene Comoretto, Mariangela Ruffolo, Danila Azzolina & Ileana Baldi. (2019) Pediatric Trials Run in India: An Analysis of Clinical Trials.gov 2006–2015. The Indian Journal of Pediatrics 86:S1, pages 10-14.
Crossref
Zahid Hussain, Colin Curtain, Corinne Mirkazemi & Syed Tabish Razi Zaidi. (2018) Peri-operative Medication Dosing in Adult Obese Elective Surgical Patients: A Systematic Review of Clinical Studies. Clinical Drug Investigation 38:8, pages 673-693.
Crossref
Marco Siccardi, Steve Rannard & Andrew Owen. (2018) The emerging role of physiologically based pharmacokinetic modelling in solid drug nanoparticle translation. Advanced Drug Delivery Reviews 131, pages 116-121.
Crossref
Mariagiovanna Scarpa, Sven Stegemann, Wen-Kai Hsiao, Heinz Pichler, Simon Gaisford, Massimo Bresciani, Amrit Paudel & Mine Orlu. (2017) Orodispersible films: Towards drug delivery in special populations. International Journal of Pharmaceutics 523:1, pages 327-335.
Crossref
Stephen H. Curry & Robin Whelpton. 2016. Introduction to Drug Disposition and Pharmacokinetics. Introduction to Drug Disposition and Pharmacokinetics 211 232 .
Michael Rieder & Daniel Hawcutt. (2016) Design and conduct of early phase drug studies in children: challenges and opportunities. British Journal of Clinical Pharmacology 82:5, pages 1308-1314.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.